Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Altered Brain GABA and Glutamate in Restless Legs Syndrome (RLS)

This study has been completed.
Information provided by (Responsible Party):
John W. Winkelman, MD, PhD, Brigham and Women's Hospital Identifier:
First received: April 22, 2010
Last updated: January 6, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)